Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Julphar
US Army
McKinsey
Farmers Insurance
Harvard Business School
Cipla
Federal Trade Commission
Dow
UBS

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087955

« Back to Dashboard

NDA 087955 describes VITAMIN K1, which is a drug marketed by Hospira and is included in three NDAs. It is available from three suppliers. Additional details are available on the VITAMIN K1 profile page.

The generic ingredient in VITAMIN K1 is phytonadione. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
Summary for 087955
Tradename:VITAMIN K1
Applicant:Hospira
Ingredient:phytonadione
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 087955
Suppliers and Packaging for NDA: 087955
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VITAMIN K1 phytonadione INJECTABLE;INJECTION 087955 ANDA Hospira, Inc. 0409-9158 0409-9158-01 5 TRAY in 1 CONTAINER (0409-9158-01) > 5 AMPULE in 1 TRAY > 1 mL in 1 AMPULE
VITAMIN K1 phytonadione INJECTABLE;INJECTION 087955 ANDA Hospira, Inc. 0409-9158 0409-9158-25 5 TRAY in 1 CONTAINER (0409-9158-25) > 5 AMPULE in 1 TRAY > 1 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:Jul 25, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
McKinsey
Citi
Harvard Business School
Queensland Health
Dow
Cerilliant
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot